Načítá se...
Selective glucocorticoid receptor-activating adjuvant therapy in cancer treatments
Although adverse effects and glucocorticoid resistance cripple their chronic use, glucocorticoids form the mainstay therapy for acute and chronic inflammatory disorders, and play an important role in treatment protocols of both lymphoid malignancies and as adjuvant to stimulate therapy tolerability...
Uloženo v:
| Vydáno v: | Oncoscience |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Impact Journals LLC
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5043069/ https://ncbi.nlm.nih.gov/pubmed/27713909 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncoscience.315 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|